{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:11:15Z","timestamp":1790082675993,"version":"4.0.1"},"reference-count":25,"publisher":"Norwegian Medical Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.21.0547","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T08:24:37Z","timestamp":1653899077000},"source":"Crossref","is-referenced-by-count":4,"title":["Deaths associated with MDMA in the period 2000\u20132019"],"prefix":"10.4045","volume":"142","author":[{"given":"Ragnhild E. G.","family":"Jamt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde M. E.","family":"Edvardsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Middelkoop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Kallevik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig T.","family":"Bogstrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete S.","family":"Vevelstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Vindenes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref=1","unstructured":"Oslo universitetssykehus. MDMA eller \"Ecstasy\". https:\/\/oslo-universitetssykehus.no\/fag-og-forskning\/nasjonale-og-regionale-tjenester\/tsb\/verktoy-for-fagutvikling\/fakta-om-rusmiddel-virkninger\/mdma-eller-ecstasy Lest 21.3.2022."},{"key":"ref=2","unstructured":"\u00c5rving AB, Middelkoop G, Hjelmeland K. Rusmiddelstatistikk: Funn i blodpr\u00f8ver hos bilf\u00f8rere mistenkt for rusp\u00e5virket kj\u00f8ring 2018. https:\/\/oslo-universitetssykehus.no\/fag-og-forskning\/nasjonale-og-regionale-tjenester\/rettsmedisinske-fag\/alkohol-og-rusmidler Lest 21.3.2022."},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Steinkellner\u00a0T, Freissmuth\u00a0M, Sitte\u00a0HH et al. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem 2011; 392: 103\u201315. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21194370&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1515%2Fbc.2011.016","DOI":"10.1515\/bc.2011.016"},{"key":"ref=4","unstructured":"H\u00f8iseth\u00a0G, L\u00f8v\u00e5sdal\u00a0\u00d8, Titze\u00a0TK et al. Psykiske og kognitive langtidseffekter av ecstasy. Tidsskr Nor L\u00e6geforen 2006; 126: 596\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16505868&dopt=Abstract"},{"key":"ref=5","unstructured":"Nielsen\u00a0S, Lundemose\u00a0JB, Simonsen\u00a0MS et al. Letalt forl\u00f8bende ecstasyforgiftning. Ugeskr Laeger 2001; 163: 2253\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11344662&dopt=Abstract"},{"key":"ref=6","unstructured":"Pettersen S, Middelkoop G, Hjelmeland K. Rusmiddelstatistikk: Funn i blodpr\u00f8ver hos bilf\u00f8rere mistenkt for rusp\u00e5virket kj\u00f8ring 2020. https:\/\/oslo-universitetssykehus.no\/fag-og-forskning\/nasjonale-og-regionale-tjenester\/rettsmedisinske-fag\/alkohol-og-rusmidler Lest 21.3.2022."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Hall\u00a0AP, Henry\u00a0JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006; 96: 678\u201385. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16595612&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fbja%2Fael078","DOI":"10.1093\/bja\/ael078"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Michael White\u00a0C. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms. J Clin Pharmacol 2014; 54: 245\u201352. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24431106&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjcph.266","DOI":"10.1002\/jcph.266"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"de la Torre\u00a0R, Ortu\u00f1o\u00a0J, Mas\u00a0M et al. Fatal MDMA intoxication. Lancet 1999; 353: 593. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10029010&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(05)75653-1","DOI":"10.1016\/S0140-6736(05)75653-1"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"de la Torre\u00a0R, Farr\u00e9\u00a0M, Ortu\u00f1o\u00a0J et al. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 2000; 49: 104\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10671903&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046%2Fj.1365-2125.2000.00121.x","DOI":"10.1046\/j.1365-2125.2000.00121.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Mueller\u00a0M, Peters\u00a0FT, Maurer\u00a0HH et al. Nonlinear pharmacokinetics of (+\/-)3,4-methylenedioxymethamphetamine (MDMA, \"Ecstasy\") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther 2008; 327: 38\u201344. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18591215&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1124%2Fjpet.108.141366","DOI":"10.1124\/jpet.108.141366"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Elliott\u00a0SP. MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission. J Anal Toxicol 2005; 29: 296\u2013300. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16105252&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fjat%2F29.5.296","DOI":"10.1093\/jat\/29.5.296"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Gouzoulis-Mayfrank\u00a0E, Daumann\u00a0J. The confounding problem of polydrug use in recreational ecstasy\/MDMA users: a brief overview. J Psychopharmacol 2006; 20: 188\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16510477&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F0269881106059939","DOI":"10.1177\/0269881106059939"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"De Letter\u00a0EA, Bouche\u00a0MP, Van Bocxlaer\u00a0JF et al. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci Int 2004; 141: 85\u201390. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15062945&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.forsciint.2003.12.015","DOI":"10.1016\/j.forsciint.2003.12.015"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Lyvers\u00a0M. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues. Drug Alcohol Rev 2006; 25: 269\u201376. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16753651&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080%2F09595230600657758","DOI":"10.1080\/09595230600657758"},{"key":"ref=16","unstructured":"LOV-2015-05-07-26. Lov om omduksjon og avgjeving av lik til undervisning og forsking. https:\/\/lovdata.no\/dokument\/LTI\/lov\/2015-05-07-26 Lest 21.3.2022."},{"key":"ref=17","unstructured":"FOR-1985-06-28-1679. Forskrift om ordningen av p\u00e5talemyndigheten. \u00a713-2. https:\/\/lovdata.no\/dokument\/SF\/forskrift\/1985-06-28-1679 Lest 21.3.2022."},{"key":"ref=18","unstructured":"Oslo universitetssykehus. Pr\u00f8vetakingsinstruks \u2013 obduksjonssaker. https:\/\/ehandboken.ous-hf.no\/document\/112685 Lest 21.3.2022."},{"key":"ref=19","unstructured":"Direktoratet for e-helse. Kodeverket ICD-10 (og ICD-11). https:\/\/www.ehelse.no\/kodeverk\/kodeverket-icd-10-og-icd-11. Lest 12.12.2021."},{"key":"ref=20","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Drug-related deaths (DRD) 2007. https:\/\/www.emcdda.europa.eu\/stats07\/DRD\/methods. Lest 8.10.2021."},{"key":"ref=21","unstructured":"Ellingsen CL, Ebbing M. Health Registries for Research Norway 2017. https:\/\/hrr.w.uib.no\/files\/2017\/02\/Kvalitetsdokument-D%C3%B8ds%C3%A5rsaksregisteret_HRR_v1.0.pdf 8.10.2021."},{"key":"ref=22","unstructured":"Kripos. Narkotika- og dopingstatistikk 2019. https:\/\/www.politiet.no\/globalassets\/04-aktuelt-tall-og-fakta\/narkotika\/narkotika-og-dopingstatistikk-kripos-2019.pdf Lest 21.3.2022."},{"key":"ref=23","unstructured":"Kripos. Narkotika- og dopingstatistikk 2016. https:\/\/www.politiet.no\/globalassets\/04-aktuelt-tall-og-fakta\/narkotika\/narkotika-og-dopingstatistikk_2016.pdf Lest 21.3.2022."},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Edland-Gryt\u00a0M, Sandberg\u00a0S, Pedersen\u00a0W. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends. Int J Drug Policy 2017; 50: 1\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28869878&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.drugpo.2017.07.030","DOI":"10.1016\/j.drugpo.2017.07.030"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Nordfj\u00e6rn\u00a0T, Bretteville-Jensen\u00a0AL, Edland-Gryt\u00a0M et al. Risky substance use among young adults in the nightlife arena: An underused setting for risk-reducing interventions? Scand J Public Health 2016; 44: 638\u201345. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27562826&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F1403494816665775","DOI":"10.1177\/1403494816665775"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["D\u00f8dsfall assosiert med MDMA i perioden 2000\u201319"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:21:38Z","timestamp":1781706098000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2022\/05\/originalartikkel\/dodsfall-assosiert-med-mdma-i-perioden-2000-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,5,24]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.21.0547","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}